دورية أكاديمية

Management of bleeding disorders in adults

التفاصيل البيبلوغرافية
العنوان: Management of bleeding disorders in adults
المؤلفون: F. Peyvandi, A.B. Federici, R. Klamoroth, M. Carcao, G. Di Minno, V. Jimenez Yuste, E. C. Rodriguez Merchan
المساهمون: F. Peyvandi, R. Klamoroth, M. Carcao, A.B. Federici, G. Di Minno, V. Jimenez-Yuste, E.C. Rodriguez Merchan
سنة النشر: 2012
المجموعة: The University of Milan: Archivio Istituzionale della Ricerca (AIR)
مصطلحات موضوعية: adults, cost-effectiveness, FVIII consumption, haemophilia A, inhibitor development, prophylaxis, Settore MED/09 - Medicina Interna
الوصف: Development of FVIII inhibitors is currently the most severe and challenging complication of haemophilia A treatment and represents a very large economic burden for a chronic disease. As a result, clinical research is making major efforts to optimize the therapeutic approaches for this condition. In this section we will review some important aspects of the management of haemophilia in adults, including an overview of bleeding in women with von Willebrand disease, an analysis of FVIII consumption in patients with severe haemophilia A, an update of the ongoing RES.I.ST study, long-term prophylaxis and experience from the Pro.Will study, current evidence relating to economic aspects of the treatment of haemophilic patients with inhibitors (based on the PROFIT study), and an overview of musculoskeletal complications in adults with severe bleeding disorders.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22530576; info:eu-repo/semantics/altIdentifier/wos/WOS:000303155600005; volume:18; issue:Suppl. 2; firstpage:24; lastpage:36; journal:HAEMOPHILIA; http://hdl.handle.net/2434/177023Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84860285376
DOI: 10.1111/j.1365-2516.2012.02797.x
الإتاحة: https://doi.org/10.1111/j.1365-2516.2012.02797.xTest
http://hdl.handle.net/2434/177023Test
رقم الانضمام: edsbas.5A26A148
قاعدة البيانات: BASE